Ed is currently a Managing Director of Precision BioVentures, LLC. Ed was a Director of Alta Partners from 2002-2013. He continues to serve as a Director of Alta BioPharma Management III, LLC and as a consultant to Alta Partners Management VIII, LLC. He currently serves on the board of directors of Applied Genetic Technologies Corporation, Cara Therapeutics, and MacroGenics and led Alta’s investments in Avid Radiopharmaceuticals, Calistoga Pharmaceuticals, ChemoCentryx, FoldRx Pharmaceuticals, Repros Therapeutics, Sunesis Pharmaceuticals, Taligen Therapeutics, Threshold Pharmaceuticals and Zafgen.
Prior to joining Alta, Ed served as Senior Vice President and CFO of Affymetrix from 1997 to 2002. From 1994 to 1997, Ed was a biotechnology research analyst for Robertson Stephens & Company, and from 1992 to 1994, was a biotechnology research analyst for Smith Barney Shearson. From 1990 to 1992, Ed practiced commercial law at Cooley Godward LLP.
Ed earned his Juris Doctor and Master of Business Administration degrees in 1990 from the University of California, Berkeley’s Boalt School of Law and Haas School of Business, respectively. Ed earned a Bachelor of Arts in Molecular Biology from Cornell University in 1985.